Skip to main content
Teva Pharmaceutical Industries Ltd. logo

Teva Pharmaceutical Industries Ltd. — Investor Relations & Filings

Ticker · TEVA ISIN · US8816242098 LEI · 549300BAFGM4RC74ZJ94 TA Manufacturing
Open in API
Filings indexed 6,067 across all filing types
Latest filing 2026-05-18 Director's Dealing
Country IL Israel
Listing TA TEVA

About Teva Pharmaceutical Industries Ltd.

https://www.tevapharm.com/

Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical company that develops, produces, and markets a broad portfolio of medicines. The company's business is centered on two main segments: generic medicines and innovative specialty treatments. As one of the world's largest manufacturers of generic drugs, Teva provides a wide range of affordable products across numerous therapeutic areas. Its specialty and biopharmaceutical research focuses on developing novel treatments, with a significant emphasis on central nervous system (CNS) disorders, including therapies for schizophrenia, tardive dyskinesia, and bipolar disorder. The company's portfolio also includes complex generics, biosimilars, and active pharmaceutical ingredients (APIs), while leveraging advanced technologies to enhance drug development and manufacturing.

Recent filings

Filing Released Lang Actions
Immediate Report
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of securities by company insiders such as directors and officers. The text includes detailed tables of securities acquired or disposed of, dates of transactions, and signatures. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is not an annual report, earnings release, or any other type of financial or regulatory report. Therefore, the correct classification is DIRS (Director's Dealing). The document length and content confirm it is a full Form 4 filing, not just an announcement or certification.
2026-05-18 Hebrew (modern)
Immediate Report
Director's Dealing Classification · 95% confidence The document is an immediate report under Israeli Securities Regulations regarding a change in holdings by an office holder, referencing a Form 4 filing by an executive (Evan Lippman). This is clearly an insider share transaction disclosure by a director/executive. Therefore, it fits the “Director’s Dealing” category (Code: DIRS).
2026-05-18 English
Immediate Report
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission (SEC), which reports changes in beneficial ownership of securities by company insiders such as officers or directors. It details transactions of shares by Eliyahu Sharon Kalif, the EVP and Chief Financial Officer of Teva Pharmaceutical Industries Limited. Form 4 is specifically used to disclose insider trading activities and personal share transactions by company directors and executives. This matches the definition of 'Director's Dealing' filings. The document is not a financial report, earnings release, or any other type of corporate report but a regulatory filing of insider transactions.
2026-05-18 Hebrew (modern)
Immediate Report
Director's Dealing Classification · 90% confidence The document is an "Immediate Report" under Israeli Securities Regulations concerning a “שינוי בהחזקות נושא משרה” (change in holdings of an office‐holder), referencing a Form 4 report by an officer. It is a disclosure of insider share transactions by a company director/executive, matching the Director’s Dealing category.
2026-05-18 English
Immediate Report
Director's Dealing Classification · 100% confidence The document is a Form 4 filing, which is used to report insider transactions of company securities by directors, officers, or significant shareholders. It details the acquisition or disposition of shares by an officer of the company, including transaction dates, amounts, and prices. This type of filing is specifically related to personal share transactions by company insiders. It is not a financial report, earnings release, or any other type of corporate announcement. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is a full Form 4 filing, not just an announcement or certification.
2026-05-07 Hebrew (modern)
Immediate Report
Director's Dealing Classification · 100% confidence The document is titled 'Immediate Report' and references a 'Form_4' related to a change in holdings by an officer (נושא משרה). It is a short report (1841 characters) and concerns insider share transactions by a company director or executive. The keywords 'שינוי בהחזקות נושא משרה' translate to 'change in holdings of an office holder,' which aligns with insider trading or director dealings. There is no financial data or report content, only a notification of a change in shareholdings by a company officer. Therefore, this document fits the category of Director's Dealing (DIRS).
2026-05-07 Hebrew (modern)

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.